Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Abadi Lestari Indonesia Tbk. (RLCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Abadi Lestari Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp3,260 (market cap 10.06T, 688.4K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 32.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 688.4K). Which is the better fit depends on your goals.
| DGNS | RLCO | |
|---|---|---|
Market Cap | 310.75B | 10.06T |
Volume | 963.6K | 688.4K |
Lot | 9.64K | 6.88K |
Turnover | 217.67M | 2.25B |
Average Price | 225.89 | 3,273.17 |
Value | 217.67M | 2.25B |
Indicative Equilibrium Price | 226 | 3,260 |
Indicative Equilibrium Volume | 1K | 15 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Abadi Lestari Indonesia Tbk.
PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →
